Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/31/2007 First Published: 1/1/1999


1.		Phase III Randomized Study of Observation Versus Chlorambucil After Anti-Helicobacter Therapy in Patients With Low Grade (Stage I) Gastric Lymphoma (Summary Last Modified 12/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 and over								BNLI-LY03 EU-98040, NCT00003617

Last Modified: 11/1/2000


2.		Phase II Study of Antibiotics and Gastric Acid Inhibition for Gastric MALT Lymphoma (Summary Last Modified 11/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 80				NCI				MDA-CPPDM-95084 NCI-T95-0003D, NCT00002682, T95-0003

Last Modified: 4/1/1999


3.		Phase II Trial of Antibiotic Eradication of Helicobacter Pylori and, Failing That, Local Therapy with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) and Involved Field Radiation in Patients with Mucosa Associated Lymphoid Tissue (MALT) Lymphomas (Summary Last Modified 04/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				SWOG-9703 S9703

Last Modified: 5/1/2000 First Published: 1/1/1998


4.		Phase II Study of Anti-Helicobacter pylori Treatment in Endoscopically Diagnosed Low Grade Localized Gastric Lymphoma (Summary Last Modified 05/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								EORTC-20961 CRC-EORTC-20961, HOVON-33, NCT00003151

Last Modified: 9/22/2004 First Published: 9/1/2000


5.		Phase II Randomized Chemoprevention Study of Dehydroepiandrosterone (DHEA) Versus Clarithromycin in Patients With Monoclonal Gammopathy of Undetermined or Borderline Significance

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Closed				18 and over				NCI				MAYO-979202 NCI-P00-0163, NCT00006219

Last Modified: 10/21/2008 First Published: 9/9/2005


6.		Phase II Study of Maintenance Therapy Comprising Thalidomide, Dexamethasone, and Clarithromycin in Patients With Multiple Myeloma Who Have Undergone Prior Autologous or Syngeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				Not specified				NCI, Pharmaceutical / Industry				FHCRC-1767.00 5589, CELGENE-FHCRC-1767.00, NCT00182663


7.		Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				0904-501 NCT00151203

Select All on One Page